🇺🇸 FDA
Patent

US 8420072

Vaccination of sex reversed hybrid tilapia (Oreochromis niloticus x O. aureus) with an inactivated Vibrio vulnificus vaccine

granted A61KA61K2039/521A61K2039/552

Quick answer

US patent 8420072 (Vaccination of sex reversed hybrid tilapia (Oreochromis niloticus x O. aureus) with an inactivated Vibrio vulnificus vaccine) held by The United States of America, as represented by the Secretary of Agriculture expires Mon Apr 11 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary of Agriculture
Grant date
Tue Apr 16 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 11 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K2039/521, A61K2039/552, A61K2039/55566, A61K39/107